Skip to content

CorVocet™ 00884450373828Recalls & reported problems

Merit Medical Systems, Inc. · Class 2

All models of CorVocet (62)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00884450373828), received between Sep 29, 2026 and Sep 29, 2026 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 1 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Hemoptysis1
  • Pneumothorax1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjurySep 29, 2026Adverse Event Without Identified Device or Use Problem

    A Merit employee conducted a CER literature search (Ortmans 2024) for the Corvocet Biopsy System. This study evaluated 240 patients. 215 patients experienced no major complications. 23 patients experienced pneumothorax requiring chest tube placement and hospitalization; 2 patients experienced events of hemoptysis requiring hospitalization with one patient requiring oxygen therapy and another patient requiring endotracheal intubation. Reference to the study: Quant Imaging Med Surg 2024;14(9):6830-6842. doi: 10.21037/qims-23-500.

    Patient problems: Hemoptysis; Pneumothorax

    MAUDE report 50934781 ↗

Other INSTRUMENT, BIOPSY devices

All INSTRUMENT, BIOPSY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page